z-logo
open-access-imgOpen Access
Oral administration of PEGylated TLR7 ligand ameliorates alcohol-associated liver disease via the induction of IL-22
Author(s) -
Qinglan Wang,
So Yeon Kim,
Hiroshi Matsushita,
Zhijun Wang,
Vijay Pandyarajan,
Michitaka Matsuda,
Koichiro Ohashi,
Takashi Tsuchiya,
Yoon Seok Roh,
Calvin Kiani,
Yutong Zhao,
Michael Chan,
Suzanne Devkota,
Shelly C. Lu,
Tomoko Hayashi,
Dennis A. Carson,
Ekihiro Seki
Publication year - 2020
Publication title -
proceedings of the national academy of sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.011
H-Index - 771
eISSN - 1091-6490
pISSN - 0027-8424
DOI - 10.1073/pnas.2020868118
Subject(s) - medicine , pharmacology , ligand (biochemistry) , oral administration , liver disease , alcohol , administration (probate law) , gastroenterology , chemistry , receptor , biochemistry , political science , law

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom